FDA endorsed the medication Lenalidomide in 2005 for treating patients with numerous myeloma, bonding subordinate pallor because of the low-or middle of the road 1-hazard myelodysplastic disorders, follicular lymphoma, minor zone lymphoma, and mantle cell lymphoma. Lenalidomide is the dynamic fixing in medication, and the idle fixings are lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate. This medication is accessible in the qualities of 5 mg, 10 mg, 15 mg, and 25 mg as containers.
Lenalidomide price in India is reasonable, and one can buy this medication from a few providers and producers of nonexclusive drugs. To purchase this medication or to know more, call 18008891064.